NNIT A/S (CPSE: NNIT)
Health Care · Health Care Technology · DK
Dkr37.35
-1.71% today · -32.7% 1Y
NNIT A/S (CPSE: NNIT) operates in the Health Care Technology industry within the Health Care sector. The company is valued at $141.76M and employs 1,500 people.
Over the last twelve months the share price has lost 32.7%, trading between 33.05 and 57.80.
Tweenvest scores NNIT A/S across four factors: quality 63/100, value 72/100, growth 6/100. Its strongest factor is value.
NNIT price history
Not enough price history to draw a chart yet.
Key figures
- Market cap
- $141.76M
- Revenue (TTM)
- $263.75M
- P/E
- —
- EPS
- -1.34
- Dividend yield
- —
- Beta (5Y)
- 0.42
- 52-week high
- Dkr57.80
- 52-week low
- Dkr33.05
- Avg volume (3M)
- —
- Shares outstanding
- 24.90M
- Employees
- 1,500
- Next earnings
- —
About NNIT A/S
NNIT A/S provides information technology solutions for life sciences, public, and private sectors in Denmark, Europe, the United States, and Asia. The company provides cybersecurity, regulatory affairs, AI, laboratory, drug safety, compliance, quality, SAP solutions, software engineering, digital manufacturing, clinical, data and cloud, supply chain, tech transition consulting, legacy transformation, and first-time launch services, as well as Microsoft and Veeva solutions, and migration solutions by valiance. NNIT A/S was founded in 1994 and is headquartered in Copenhagen, Denmark.
- ISIN
- DK0060580512
- Founded
- 1994
- Listed since
- Mar 6, 2015
- Exchange
- OMX Nordic Exchange Copenhagen
- Currency
- DKK
Other Health Care Technology companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| Cegedim SAENXTPA: ALCGM | $164.51M | €10.60 | -0.93% |
| OptimizeRx CorporationNasdaqCM: OPRX | $155.96M | $8.21 | -0.91% |
| Kanamic Network Co.,LTDTSE: 3939 | $149.86M | ¥500.00 | +2.04% |
| Median Technologies SAENXTPA: ALMDT | $145.51M | €3.77 | +10.72% |
| Hydreight Technologies Inc.TSXV: NURS | $136.92M | CA$3.64 | +5.20% |
| FINDEX Inc.TSE: 3649 | $133.58M | ¥866.00 | +2.73% |
| Health Catalyst, Inc.NasdaqGS: HCAT | $133.20M | $1.72 | -2.82% |
| LifeMD, Inc.NasdaqGM: LFMD | $126.77M | $2.60 | -1.14% |
Figures last refreshed Oct 11, 2026.